V022-2357 Screening compound: 2-{6-[1-(2-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]-7-methyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl}-N-[(pyridin-4-yl)methyl]acetamide

V022-2357 Screening compound: 2-{6-[1-(2-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]-7-methyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl}-N-[(pyridin-4-yl)methyl]acetamide
V022-2357 Screening compound: 2-{6-[1-(2-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]-7-methyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl}-N-[(pyridin-4-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-2357
2-{6-[1-(2-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]-7-methyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl}-N-[(pyridin-4-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-2357

Molecular Formula

C26H24N6O3S (C26 H24 N6 O3 S)

Compound Name

2-{6-[1-(2-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]-7-methyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl}-N-[(pyridin-4-yl)methyl]acetamide

IUPAC name

2-{6-[1-(2-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]-7-methyl-5-oxo-5H-[13]thiazolo[32-a]pyrimidin-3-yl}-N-[(pyridin-4-yl)methyl]acetamide

SMILES

Cc1cc(C2=C(C)N=C3SC=C(CC(NCc4ccncc4)=O)N3C2=O)nn1-c(cccc1)c1OC

InChI

InChI=1S/C26H24N6O3S/c1-16-12-20(30-32(16)21-6-4-5-7-22(21)35-3)24-17(2)29-26-31(25(24)34)19(15-36-26)13-23(33)28-14-18-8-10-27-11-9-18/h4-12,15H,13-14H2,1-3H3,(H,28,33)

InChI Key

MJNQBWUUACYULN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19856532

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

500.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.785

Distribution Coefficient, logD

1.782

Water Solubility, LogSw

-2.16

Polar Surface Area

79.882

Acid Dissociation Constant (pKa)

14.02

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.23

V022-2357 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with V022-2357 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-2357?
Check Price and Availability of V022-2357, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-2357 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-2357
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-2357
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-2357 available by request